DETERMINANT SELECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED ANTIGENIC PEPTIDES IS EXPLAINED BY CLASS I-PEPTIDE AFFINITY AND IS STRONGLY INFLUENCED BY NONDOMINANT ANCHOR RESIDUES

被引:206
作者
CHEN, WS
KHILKO, S
FECONDO, J
MARGULIES, DH
MCCLUSKEY, J
机构
[1] FLINDERS UNIV S AUSTRALIA,MED CTR,CTR TRANSFUS MED & IMMUNOL,BEDFORD PK,SA 5042,AUSTRALIA
[2] NIAID,IMMUNOL LAB,BETHESDA,MD 20892
[3] SWINBURNE UNIV TEHCNOL,DEPT APPL CHEM,HAWTHORN,VIC 3122,AUSTRALIA
关键词
D O I
10.1084/jem.180.4.1471
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The contribution of major histocompatibility complex (MHC) class I-peptide affinity to immunodominance of particular peptide antigens (Ags) in the class I-restricted cytotoxic T lymphocyte (CTL) response is not clearly established. Therefore, we have compared the H-2K(b)-restricted binding and presentation of the immunodominant ovalbumin (OVA)(257-264) (SIINFEKL) determinant to that of a subdominant OVA determinant OVA(55-62) (KVVRFDKL). Immuno-dominance of OVA(257-264) was not attributable to the specific T cell repertoire but correlated instead with more efficient Ag presentation. This enhanced Ag presentation could be accounted for by the higher affinity of K-b/OVA(257-264) compared with K-b/OVA(55-62) despite the presence of a conserved K-b-binding motif in both peptides. Kinetic binding studies using purified soluble H-2K(b) molecules (K-s(b)) and biosensor techniques indicated that the K-on for association of OVA(257-264-C6) and K-s(b) at 25 degrees C was similar to 10-fold faster (5.9 x 10(3) M(-1) s(-1) versus 6.5 x 10(2) M(-1) s(-1)), and the K-off approximately twofold slower (9.1 x 10(-6) s(-1) versus 1.6 x 10(-5) s(-1)), than the rate constants for interaction of OVA(55-62-C6) and K-s(b). The association of these peptides with K-b was significantly influenced by multiple residues at presumed nonanchor sites within the peptide sequence. The contribution of each peptide residue to K-b-binding was dependent upon the sequence context and the summed contributions were not additive. Thus the affinity of MHC class I-peptide binding is a critical factor controlling presentation of peptide Ag and immunodominance in the class I-restricted CTL response.
引用
收藏
页码:1471 / 1483
页数:13
相关论文
共 70 条
[1]   MECHANISMS INFLUENCING THE IMMUNODOMINANCE OF T-CELL DETERMINANTS [J].
ADORINI, L ;
APPELLA, E ;
DORIA, G ;
NAGY, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) :2091-2104
[2]  
AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914
[3]   RECOGNITION OF CLONED INFLUENZA-VIRUS HEMAGGLUTININ GENE-PRODUCTS BY CYTOTOXIC LYMPHOCYTES-T [J].
BENNINK, JR ;
YEWDELL, JW ;
SMITH, GL ;
MOSS, B .
JOURNAL OF VIROLOGY, 1986, 57 (03) :786-791
[4]   MURINE CYTO-TOXIC LYMPHOCYTE-T RECOGNITION OF INDIVIDUAL INFLUENZA-VIRUS PROTEINS - HIGH-FREQUENCY OF NONRESPONDER MHC CLASS-I ALLELES [J].
BENNINK, JR ;
YEWDELL, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (05) :1935-1939
[5]   PEPTIDE-INDUCED CONFORMATIONAL-CHANGES IN CLASS-I HEAVY-CHAINS ALTER MAJOR HISTOCOMPATIBILITY COMPLEX RECOGNITION [J].
BLUESTONE, JA ;
JAMESON, S ;
MILLER, S ;
DICK, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1757-1761
[6]  
BOEHNCKE WH, 1993, J IMMUNOL, V150, P331
[7]   THE SIMULTANEOUS MULTIPLE PRODUCTION OF SOLUTION PHASE PEPTIDES - ASSESSMENT OF THE GEYSEN METHOD OF SIMULTANEOUS PEPTIDE-SYNTHESIS [J].
BRAY, AM ;
MAEJI, NJ ;
GEYSEN, HM .
TETRAHEDRON LETTERS, 1990, 31 (40) :5811-5814
[8]   REACTIVITY OF V-BETA17A+ CD8+ T-CELL HYBRIDS - ANALYSIS USING A NEW CD8+ T-CELL FUSION PARTNER [J].
BURGERT, HG ;
WHITE, J ;
WELTZIEN, HU ;
MARRACK, P ;
KAPPLER, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :1887-1904
[9]   THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
MILES, C ;
GREY, HM .
SCIENCE, 1987, 235 (4794) :1353-1358
[10]   T-CELL RECEPTOR ALPHA-CHAIN PAIRING DETERMINES THE SPECIFICITY OF RESIDUE-262 WITHIN THE KB-RESTRICTED, OVALBUMIN257-264 DETERMINANT [J].
CARBONE, FR ;
STERRY, SJ ;
BUTLER, J ;
RODDA, S ;
MOORE, MW .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (08) :861-867